Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2020

• Venue

  CNS Drugs

• Publication date

  2020-05-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s40263-020-00737-1PMID 32458360PMCID PMC9020372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Knock-on effect of periodontitis to the pathogenesis of Alzheimer’s disease?

  2020cited by this paper
• Correction to: Knock-on effect of periodontitis to the pathogenesis of Alzheimer’s disease?

  2020cited by this paper
• Linking mechanisms of periodontitis to Alzheimer's disease.

  2020cited by this paper
• Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer's disease

  2020cited by this paper
• Studies on citrullinated LL-37: detection in human airways, antibacterial effects and biophysical properties

  2020cited by this paper
• Systemic inflammatory impact of periodontitis on cognitive impairment.

  2020cited by this paper
• Acute bacterial meningitis and stroke.

  2019cited by this paper
• Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer’s Disease?

  2019cited by this paper
• Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota

  2019cited by this paper
• The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system

  2019cited by this paper
• A genetic signature including apolipoprotein Eε4 potentiates the risk of herpes simplex–associated Alzheimer's disease

  2019cited by this paper
• Effect of Systemic Inflammation on Rat Attentional Function and Neuroinflammation: Possible Protective Role for Food Restriction

  2019cited by this paper
• Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

  2019cited by this paper
• Antibiotics, gut microbiota, and Alzheimer’s disease

  2019cited by this paper
• Assessing the role of Porphyromonas gingivalis in periodontitis to determine a causative relationship with Alzheimer’s disease

  2019cited by this paper
• Blood-Brain Barrier: From Physiology to Disease and Back.

  2019cited by this paper
• Infection-Induced Systemic Inflammation Is a Potential Driver of Alzheimer's Disease Progression

  2019cited by this paper
• Awareness and practices of general practitioners towards the oral-systemic disease relationship: A regionwide survey in France.

  2019cited by this paper
• A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment

  2019cited by this paper
• Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors

  2019cited by this paper
• The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages

  2019influential reference
• Continuous intracerebroventricular injection of Porphyromonas gingivalis lipopolysaccharide induces systemic organ dysfunction in a mouse model of Alzheimer's disease

  2019cited by this paper
• Immune-Mediated Control of a Dormant Neurotropic RNA Virus Infection

  2019cited by this paper
• FGF Gradient Controls Boundary Position Between Proliferating and Differentiating Cells and Regulates Lacrimal Gland Growth Dynamics

  2019cited by this paper
• Distal Consequences of Oral Inflammation

  2019cited by this paper
• Calreticulin and Galectin-3 Opsonise Bacteria for Phagocytosis by Microglia

  2019cited by this paper
• Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment

  2019cited by this paper
• The Possible Causal Link of Periodontitis to Neuropsychiatric Disorders: More Than Psychosocial Mechanisms

  2019cited by this paper
• Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF‐α production in human macrophages and cross the blood‐brain barrier in mice

  2019cited by this paper
• The Evolving Concept of the Blood Brain Barrier (BBB): From a Single Static Barrier to a Heterogeneous and Dynamic Relay Center

  2019cited by this paper
• The Immune System and Its Dysregulation with Aging.

  2019cited by this paper
• Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease

  2019cited by this paper
• Undigested Food and Gut Microbiota May Cooperate in the Pathogenesis of Neuroinflammatory Diseases: A Matter of Barriers and a Proposal on the Origin of Organ Specificity

  2019cited by this paper
• NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome

  2019cited by this paper
• Azithromycin treats diffuse panbronchiolitis by targeting T cells via inhibition of mTOR pathway.

  2019cited by this paper
• Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.

  2019cited by this paper
• Exploring the “Multiple-Hit Hypothesis” of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat

  2019cited by this paper
• Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms

  2019cited by this paper
• Human Inflammaging

  2019cited by this paper
• Genetic Risk Factors for Alzheimer Disease: Emerging Roles of Microglia in Disease Pathomechanisms.

  2019cited by this paper
• Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease

  2019cited by this paper
• Small molecules as therapeutic drugs for Alzheimer's disease

  2019cited by this paper
• Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan

  2019cited by this paper
• Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer’s disease?

  2019cited by this paper
• Chronic Low-grade Inflammatory Phenotype (CLIP) and Senescent Immune Dysregulation.

  2019cited by this paper
• Herpesviral infections and antimicrobial protection for Alzheimer's disease: Implications for prevention and treatment

  2019cited by this paper
• Porphyromonas gingivalis Infection Induces Amyloid-β Accumulation in Monocytes/Macrophages

  2019cited by this paper
• Blood Pressure Variability and Progression of Clinical Alzheimer Disease.

  2019cited by this paper
• Antidiabetic therapies and Alzheimer disease

  2019cited by this paper
• Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease

  2019cited by this paper
• Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment

  2019cited by this paper
• Doxycycline for Alzheimer’s Disease: Fighting β-Amyloid Oligomers and Neuroinflammation

  2019cited by this paper
• The Post-amyloid Era in Alzheimer's Disease: Trust Your Gut Feeling

  2019cited by this paper
• Gut Microbiota: From the Forgotten Organ to a Potential Key Player in the Pathology of Alzheimer’s Disease

  2019cited by this paper
• Porphyromonas gingivalis induces depression via downregulating p75NTR-mediated BDNF maturation in astrocytes.

  2019cited by this paper
• Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking “Inflammaging” in Patients with Systemic Lupus Erythematosus

  2019cited by this paper
• Shear-induced amyloid formation of IDPs in the brain.

  2019cited by this paper
• Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression

  2019cited by this paper
• Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives

  2019cited by this paper
• Iron Pathophysiology in Alzheimer's Diseases.

  2019cited by this paper
• The Vascular Hypothesis of Alzheimer’s Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging

  2018cited by this paper
• Cellular senescence: Immunosurveillance and future immunotherapy.

  2018cited by this paper
• Modulating bacterial and gut mucosal interactions with engineered biofilm matrix proteins

  2018cited by this paper
• Ageing, Cellular Senescence and Neurodegenerative Disease

  2018cited by this paper
• Neurophagy, the phagocytosis of live neurons and synapses by glia, contributes to brain development and disease

  2018cited by this paper
• Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines

  2018cited by this paper
• Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer’s Disease

  2018cited by this paper
• Role of Microbes in the Development of Alzheimer’s Disease: State of the Art – An International Symposium Presented at the 2017 IAGG Congress in San Francisco

  2018cited by this paper
• Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure.

  2018cited by this paper
• Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial–Host Interactions Facilitate the Bacterial Pathogen Invading the Brain

  2018cited by this paper
• Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy

  2018cited by this paper
• mTOR Regulation of Glycolytic Metabolism in T Cells

  2018cited by this paper
• The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease

  2018cited by this paper
• Endoplasmic reticulum stress-induced apoptosis in intestinal epithelial cells: a feed-back regulation by mechanistic target of rapamycin complex 1 (mTORC1)

  2018cited by this paper
• Lipopolysaccharide endotoxemia induces amyloid-β and p-tau formation in the rat brain.

  2018cited by this paper
• Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease.

  2018cited by this paper
• NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies

  2018cited by this paper
• The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review

  2018cited by this paper
• Can an Infection Hypothesis Explain the Beta Amyloid Hypothesis of Alzheimer’s Disease?

  2018cited by this paper
• Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease

  2018cited by this paper
• Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future

  2018cited by this paper
• Viral Hypothesis and Antiviral Treatment in Alzheimer’s Disease

  2018cited by this paper
• Fueling thought: Management of glycolysis and oxidative phosphorylation in neuronal metabolism

  2018cited by this paper
• Differentiation and Maturation of Oligodendrocytes in Human Three-Dimensional Neural Cultures

  2018cited by this paper
• Phagocytic Roles of Glial Cells in Healthy and Diseased Brains

  2018cited by this paper
• Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers

  2018cited by this paper
• Herpes Simplex Virus, APOEɛ4, and Cognitive Decline in Old Age: Results from the Betula Cohort Study

  2018cited by this paper
• Increased BBB Permeability Enhances Activation of Microglia and Exacerbates Loss of Dendritic Spines After Transient Global Cerebral Ischemia

  2018cited by this paper
• Gut Microbiota is Altered in Patients with Alzheimer’s Disease

  2018cited by this paper
• Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction

  2018cited by this paper
• Bovine Lactoferrin Enhances TLR7-Mediated Responses in Plasmacytoid Dendritic Cells in Elderly Women: Results From a Nutritional Intervention Study With Bovine Lactoferrin, GOS and Vitamin D

  2018cited by this paper
• The Gut Microbiome as a Major Regulator of the Gut-Skin Axis

  2018cited by this paper
• Cellular Senescence and Inflammaging in Age-Related Diseases

  2018cited by this paper
• Microbiome–microglia connections via the gut–brain axis

  2018cited by this paper
• Azithromycin and Roxithromycin define a new family of “senolytic” drugs that target senescent human fibroblasts

  2018cited by this paper
• Neuroinflammation, Gut Microbiome, and Alzheimer’s Disease

  2018cited by this paper
• Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease

  2018cited by this paper
• Alzheimer's disease: The right drug, the right time

  2018cited by this paper
• The Possibility of an Infectious Etiology of Alzheimer Disease

  2018cited by this paper
• Source of Chronic Inflammation in Aging

  2018cited by this paper

• Gut-brain axis in health and brain disease.

  2026cites this paper
• Traffic-related air pollution significantly aggravates the detrimental effect of infections on the risk of Alzheimer’s disease and other dementias, especially in non-carriers of APOE4

  2026cites this paper
• Nanoengineered Polyphenol-Quantum Dot Conjugates Inhibit Biofilm Protein-Aβ42 Heterotypic Fibrillogenesis, Restore Synaptic Transmission, and Suppress Apoptosis in Alzheimer's Disease.

  2025cites this paper
• The role of probiotics, prebiotics, and postbiotics: cellular and molecular pathways activated on glial cells in Alzheimer’s disease

  2025cites this paper
• Biofilm Biology to Brain Health: Harnessing Microbial Wisdom to Uncover Amyloid Dissociating Bifunctional Nano Chaperones for Alzheimer's Therapeutics.

  2025cites this paper
• Are current etiological theories of Alzheimer’s disease falsifiable? An epistemological assessment

  2025cites this paper
• Gut microbiota in Alzheimer's disease: understanding molecular pathways and potential therapeutic perspectives.

  2025cites this paper
• Journal of Population Therapeutics & Clinical Pharmacology

  2024cites this paper
• Elevated lipopolysaccharide binding protein in Alzheimer’s disease patients with APOE3/E3 but not APOE3/E4 genotype

  2024cites this paper
• A Scoping Review of Alzheimers Disease Hypotheses: An Array of Uni- and Multi-Factorial Theories

  2024cites this paper
• The association between memory, COVID-19 testing, and COVID-19 incidence in middle-aged and older adults: a prospective analysis of the CLSA

  2024cites this paper
• Molecular Mechanisms Linking Osteoarthritis and Alzheimer’s Disease: Shared Pathways, Mechanisms and Breakthrough Prospects

  2024cites this paper
• Prior infections are associated with smaller hippocampal volume in older women

  2024cites this paper
• Alleviation of Cognitive Impairment-like Behaviors, Neuroinflammation, Colitis, and Gut Dysbiosis in 5xFAD Transgenic and Aged Mice by Lactobacillus mucosae and Bifidobacterium longum

  2023cites this paper
• Probiotic Bifidobacterium breve MCC1274 Protects against Oxidative Stress and Neuronal Lipid Droplet Formation via PLIN4 Gene Regulation

  2023cites this paper
• A SCOPING REVIEW OF ALZHEIMERS DISEASE HYPOTHESES: THE CASE FOR A MULTI-FACTORIAL THEORY

  2023influential citation
• Evidence supportive of a bacterial component in the etiology for Alzheimer’s disease and for a temporal-spatial development of a pathogenic microbiome in the brain

  2023cites this paper
• A glance through the effects of CD4+ T cells, CD8+ T cells, and cytokines on Alzheimer's disease

  2023cites this paper
• Evidence for the Existence of a Bacterial Etiology for Alzheimer’s Disease and for a Temporal-Spatial Development of a Pathogenic Microbiome in the Brain

  2022cites this paper
• Dual role of the nasal microbiota in neurological diseases-An unignorable risk factor or a potential therapy carrier.

  2022cites this paper
• Immune system aging and the aging-related diseases in the COVID-19 era

  2022cites this paper
• NDT_A_264910 1311..1339

  2021cites this paper
• The role of inflammaging in the development of chronic diseases of older people

  2021cites this paper
• Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease

  2021cites this paper
• Multi-pathogen infections and Alzheimer’s disease

  2021cites this paper
• Red Cell Distribution Width, Anemia, and Brain Volumetric Outcomes Among Middle-Aged Adults

  2021cites this paper
• Immunosenescence and Alzheimer’s Disease

  2021cites this paper
• Increased Occurrence of Treponema spp. and Double-species Infections in Patients with Alzheimer’s Disease

  2021cites this paper
• Evidence for aggregation-independent, PrPC-mediated Aβ cellular internalization

  2020cites this paper
• Why we should use Topological Data Analysis in Ageing: towards defining the "Topological shape of ageing".

  2020cites this paper